Antimicrobial stewardship program: Difference between revisions

From IDWiki
No edit summary
No edit summary
Line 7: Line 7:
=== Hospital Leadership Commitment ===
=== Hospital Leadership Commitment ===
* Need support from senior leadership, including chief medical officer, chief nursing officer, and director of pharmacy
* Need support from senior leadership, including chief medical officer, chief nursing officer, and director of pharmacy

* Need leaders to give time to manage the program, resource (including staffing)
* Need leaders to give time to manage the program, resource (including staffing)
* Leaders should champion the program
* Accountability and responsibilities
* Regular reporting to senior leadership
* Available expertise on infection management

* Education and practical training
=== Accountability ===
* Other actions aiming at responsible antimicrobial use
* The leaders must be accountable for management and outcomes
* Monitoring and surveillance
* Co-leaders should have clear delineation of responsibilities and expectations
* Reporting and feedback

=== Pharmacy Expertise ===
* Available expertise on infection management from ID-trained pharmacists or, if none exists, general clinical pharmacists

=== Action ===
* Choose interventions that will best improve outcomes
* The most effective evidence-based interventions are:
** Prospective audit and feedback, which can be made more effective with face-to-face meetings with prescribers ("handshake stewardship")
** Preauthorization
* Other interventions include:
** Facility-specific treatment guidelines, particularly for CAP, UTI, and SSTI, but possibly also for [[sepsis]], [[Staphylococcus aureus]] infection, [[Clostridioides difficile]] infection, and [[OPAT]]
** Antibiotic timeouts, with scheduled reassessment at 48-72 hours by the prescriber
*** Not a substitution for prospective audit and feedback
*** May not decrease antimicrobial use, but may improve appropriateness
** Assessing penicillin allergy
*** History, challenge doses, and skin testing
*** May involve nurses for the assessments
* Pharmacy-based interventions include:
** Documentation of indication for antibiotics can improve antibiotic use
** Automatic substitutions from IV to oral therapy
** Interventions to reduce the duration of antibiotics to shortest effective duration
** Dose adjustments and optimization
*** PK monitoring and adjustment of [[aminoglycosides]] and [[vancomycin]]
*** Alternative dosing of β-lactams
** Duplicative therapy alerts
** Time-sensitive automatic stop orders
** Detection and prevention of [[drug-drug interactions]]
** Reducing use of antibiotics with increased risk of [[Clostridioides difficile]] infection
* Microbiology- and laboratory-based interventions include:
** Selective reporting of susceptibility testing
** Comments in microbiology reports
** Development of stratified antibiograms (e.g. by location or age)
** Rapid viral testing for respiratory pathogens to reduce the use of inappropriate antibiotics
** Rapid diagnostic testing on blood specimens
** Serial procalcitonin in ICU patients
* Nursing-based interventions include:
** Optimizing microbiology culture collection
** IV to oral transitions
** Prompting antibiotic timeouts

=== Tracking ===

==== Antimicrobial Use ====

* Days of therapy (DOTs) or defined daily doses (DDDs)
* Stadardized antimicrobial administration ratio (SAAR), which compares actual use to expected use based on a statistical model

==== Outcome Measures ====

* [[Clostridioides difficile]] infection rates
* [[Antimicrobial resistance]]
* Financial impact, though costs often stabilize after initial improvement

==== Process Measures for QI ====


* For prospective audit and feedback, tracking the types of recommendations and whether they are accepted
== Possible Interventions ==
* For preauthorization, tracking agents that are generating requests and ensuring that preauthorization is not delaying appropriate therapy
* For facility-specific treatment guidelines, monitoring adherence
* Others can include:
** Monitoring how often antibiotic timeouts are done and if changes are made
** Evaluating medication use for select antibiotics, typically using standardized audit forms
** Monitoring conversions from IV to oral antimicrobials
** Monitoring the frequency of duplicative therapy (e.g. double anaerobic coverage)
** Assessing the appropriateness of discharge antibiotics and durations


=== Reporting ===
* Preauthorization
* Regular updates to prescribers, pharmacists, nurses, and leadership on both outcome and process measures
* Prospective audit and feedback
* Provider-specific reports with comparisons to peers can be helpful
* Didactic educational activities, including lectures and pamphlets
* Facility-specific clinical practice guidelines for common syndromes
* Reducing use of antibiotics with increased risk of [[C. difficile infection]]
* Prescriber-led review, including antibiotics time-outs and stop orders
* Computerized clinical decision-making support at the time of prescribing
* PK monitoring and adjustment of [[aminoglycosides]] and [[vancomycin]]
* Alternative dosing of β-lactams
* Interventions to increase the use of oral antibiotics for initial therapy as well as timely transition from IV to oral antibiotics
* Interventions to reduce the duration of antibiotics to shortest effective duration
* Allergy assessments and penicillin skin testing for patients with reported [[β-lactam allergy]]
* Development of stratified antibiograms (e.g. by location or age)
* Selective and cascade reporting of antimicrobial susceptibility
* Rapid viral testing for respiratory pathogens to reduce the use of inappropriate antibiotics
* Rapid diagnostic testing on blood specimens
* Serial [[procalcitonin]] in ICU patients


=== Recommended Against ===
=== Education ===
* Education and practical training is helpful but not enough
* May include didactic presentations, posters, flyers, and newsletters, and mailing list emails


== Ineffective Interventions ==
* Cycling antibiotics
* Cycling antibiotics



Revision as of 18:33, 10 August 2022

Background

  • Program to ensure that antimicrobials are used appropriately, in order to improve patient outcomes

Core Elements

Hospital Leadership Commitment

  • Need support from senior leadership, including chief medical officer, chief nursing officer, and director of pharmacy
  • Need leaders to give time to manage the program, resource (including staffing)
  • Leaders should champion the program
  • Regular reporting to senior leadership

Accountability

  • The leaders must be accountable for management and outcomes
  • Co-leaders should have clear delineation of responsibilities and expectations

Pharmacy Expertise

  • Available expertise on infection management from ID-trained pharmacists or, if none exists, general clinical pharmacists

Action

  • Choose interventions that will best improve outcomes
  • The most effective evidence-based interventions are:
    • Prospective audit and feedback, which can be made more effective with face-to-face meetings with prescribers ("handshake stewardship")
    • Preauthorization
  • Other interventions include:
    • Facility-specific treatment guidelines, particularly for CAP, UTI, and SSTI, but possibly also for sepsis, Staphylococcus aureus infection, Clostridioides difficile infection, and OPAT
    • Antibiotic timeouts, with scheduled reassessment at 48-72 hours by the prescriber
      • Not a substitution for prospective audit and feedback
      • May not decrease antimicrobial use, but may improve appropriateness
    • Assessing penicillin allergy
      • History, challenge doses, and skin testing
      • May involve nurses for the assessments
  • Pharmacy-based interventions include:
    • Documentation of indication for antibiotics can improve antibiotic use
    • Automatic substitutions from IV to oral therapy
    • Interventions to reduce the duration of antibiotics to shortest effective duration
    • Dose adjustments and optimization
    • Duplicative therapy alerts
    • Time-sensitive automatic stop orders
    • Detection and prevention of drug-drug interactions
    • Reducing use of antibiotics with increased risk of Clostridioides difficile infection
  • Microbiology- and laboratory-based interventions include:
    • Selective reporting of susceptibility testing
    • Comments in microbiology reports
    • Development of stratified antibiograms (e.g. by location or age)
    • Rapid viral testing for respiratory pathogens to reduce the use of inappropriate antibiotics
    • Rapid diagnostic testing on blood specimens
    • Serial procalcitonin in ICU patients
  • Nursing-based interventions include:
    • Optimizing microbiology culture collection
    • IV to oral transitions
    • Prompting antibiotic timeouts

Tracking

Antimicrobial Use

  • Days of therapy (DOTs) or defined daily doses (DDDs)
  • Stadardized antimicrobial administration ratio (SAAR), which compares actual use to expected use based on a statistical model

Outcome Measures

Process Measures for QI

  • For prospective audit and feedback, tracking the types of recommendations and whether they are accepted
  • For preauthorization, tracking agents that are generating requests and ensuring that preauthorization is not delaying appropriate therapy
  • For facility-specific treatment guidelines, monitoring adherence
  • Others can include:
    • Monitoring how often antibiotic timeouts are done and if changes are made
    • Evaluating medication use for select antibiotics, typically using standardized audit forms
    • Monitoring conversions from IV to oral antimicrobials
    • Monitoring the frequency of duplicative therapy (e.g. double anaerobic coverage)
    • Assessing the appropriateness of discharge antibiotics and durations

Reporting

  • Regular updates to prescribers, pharmacists, nurses, and leadership on both outcome and process measures
  • Provider-specific reports with comparisons to peers can be helpful

Education

  • Education and practical training is helpful but not enough
  • May include didactic presentations, posters, flyers, and newsletters, and mailing list emails

Ineffective Interventions

  • Cycling antibiotics

Further Reading

  • How to start an antimicrobial stewardship programme in a hospital. Clin Microbiol Infect. 2019;26(4):447-453. doi: 10.1016/j.cmi.2019.08.007
  • Implementing an Antibiotic Stewardship Program: Guidelines by the IDSA and the SHEA. Clin Infect Dis. 2016;62(10):e51-e77. doi: 10.1093/cid/ciw118
  • IDSA and the SHEA Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship. Clin Infect Dis. 2007;44:159-77. doi: 10.1086/510393